Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Michel

Showing results (81-90 of 243) with videos related to

Pageof 25
Sort By:
Analytical and Quantitative Cytology and Histology|September 9, 2008
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasiaMartin Voss, Lutz Trojan, Annette Steidler, et al.
BJU International|March 16, 2006
Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumoursAxel Häcker, Stefan Vallo, Christel Weiss, et al.
European Urology Focus|May 17, 2025
Bridging Vision and Text: Applications and Challenges of Vision-Language Models in Urological SurgeryWouter Bogaert, Nicolas Carl, Karl-Friedrich Kowalewski, et al.
The Prostate|April 12, 2011
Neuroendocrine tumor cells in prostate cancer: evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-upElmar Heinrich, Lutz Trojan, Dorothee Friedrich, et al.
Plos One|October 4, 2011
Phase resetting of the mammalian circadian clock relies on a rapid shift of a small population of pacemaker neuronsJos H T Rohling, Henk Tjebbe vanderLeest, Stephan Michel, et al.
Journal of Endourology|June 30, 2009
Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomyFelix Wezel, Charalampos Mamoulakis, Jorge Rioja, et al.
Anticancer Research|August 28, 2004
Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cellsMaurice Stephan Michel, Philipp Erben, Lutz Trojan, et al.
Anticancer Research|July 28, 2004
Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluationLutz Trojan, Daniel Thomas, Dorothee Friedrich, et al.
European Urology|July 28, 2005
Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devicesAxel Häcker, Stefan Vallo, Christel Weiss, et al.
European Urology|January 3, 2006
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical stagingLutz Trojan, Christian Bode, Christel Weiss, et al.
Pageof 25

Showing results (81-90 of 243) with videos related to

Sort By:
Pageof 25
Analytical and Quantitative Cytology and Histology|September 9, 2008
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasiaMartin Voss, Lutz Trojan, Annette Steidler, et al.
BJU International|March 16, 2006
Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumoursAxel Häcker, Stefan Vallo, Christel Weiss, et al.
European Urology Focus|May 17, 2025
Bridging Vision and Text: Applications and Challenges of Vision-Language Models in Urological SurgeryWouter Bogaert, Nicolas Carl, Karl-Friedrich Kowalewski, et al.
The Prostate|April 12, 2011
Neuroendocrine tumor cells in prostate cancer: evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-upElmar Heinrich, Lutz Trojan, Dorothee Friedrich, et al.
Plos One|October 4, 2011
Phase resetting of the mammalian circadian clock relies on a rapid shift of a small population of pacemaker neuronsJos H T Rohling, Henk Tjebbe vanderLeest, Stephan Michel, et al.
Journal of Endourology|June 30, 2009
Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomyFelix Wezel, Charalampos Mamoulakis, Jorge Rioja, et al.
Anticancer Research|August 28, 2004
Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cellsMaurice Stephan Michel, Philipp Erben, Lutz Trojan, et al.
Anticancer Research|July 28, 2004
Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluationLutz Trojan, Daniel Thomas, Dorothee Friedrich, et al.
European Urology|July 28, 2005
Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devicesAxel Häcker, Stefan Vallo, Christel Weiss, et al.
European Urology|January 3, 2006
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical stagingLutz Trojan, Christian Bode, Christel Weiss, et al.
Pageof 25